REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. filed a 10-Q quarterly report on October 29, 2021, under the ticker PAIC, associated with Panacea Acquisition Corp. II, a blank-check company sponsored by Panacea Acquisition Holdings II LLC. Panacea Acquisition Corp. II conducted its initial public offering in 2021, targeting the healthcare and life sciences sector. The filing reflects the company's reporting obligations during the SPAC merger process, with Revelation Biosciences operating as a clinical-stage life sciences company focused on innate immune system therapeutics. The combined entity proceeded through the de-SPAC transaction following the filing period. For complete filing history, transaction timelines, and sponsor data on PAIC and thousands of other SPACs, sign up for full access at SpacDesk.